5Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS,Gomer CJ. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.Cancer Res 2000; 60:4066-4069.
6Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364.
7Gleich LL, Zimmerman N, Wang YO, Gluckman JL. Angiogenic inhibition for treatment of head and neck cancer. Anticancer Res 1998; 18:2607-2610.
8Yanase T, Tamura M, Fulita K, Kodama S, Tanaka K. Inhibitory effect of angiogenesis inhibitor TPN-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 1993; 53:2566-2570.
9Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J. Synthetic analogues fumagillin that inhibit angiogenesis and suppress turnout growth. Nature 1990; 348:555-557.
10Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K,Fujita T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetylcarbamoyl) fumagillin (TNP-470; AGM 1470). Cancer Res 1993;53:4262-4267.
